Prognostic Value of Inflammatory Cytokines in Predicting Hospital Readmissions in Heart Failure with Preserved Ejection Fraction
DOI: https://doi.org/10.2147/jir.s459989
IF: 4.5
2024-05-15
Journal of Inflammation Research
Abstract:Zhihao Zhao, 1, &ast Diya Qi, 1, &ast Zeqing Zhang, 2, &ast Xin Du, 3 Fengyun Zhang, 2 Ruicong Ma, 4 Yi Liang, 1 Yuewu Zhao, 1 Ying Gao, 1 Yu Yang 2 1 Department of Cardiology, the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, Xuzhou, People's Republic of China; 2 Department of Cardiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China; 3 Department of Neurology, the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, Xuzhou, People's Republic of China; 4 Graduate School, Dalian Medical University, Dalian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ying Gao, Department of Cardiology, the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, Xuzhou, People's Republic of China, Tel +86-13951461302, Email Yu Yang, Department of Cardiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China, Tel +86-15651359875, Email Purpose: The aim of this study was to explore the relationship between inflammatory cytokines and the risk of heart failure (HF) readmission in patients with heart failure with preserved ejection fraction (HFpEF). Patients and Methods: We enrolled 429 patients with HFpEF admitted to the cardiology department in our hospital from January 2020 to July 2022. The patients were divided into the readmission or non-readmission groups according to whether they were readmitted for heart failure within 1 year of discharge. The clinical features and laboratory date of the subjects were collected and analyzed. Multivariate cox regression analysis was used to identify predictors of HF readmission. In addition, receiver operating characteristic (ROC) curves were used to determine the prognostic value of each factor. Results: The levels of IL-1β, IL-6, IL-10, IL-17, TNF-α, NT-proBNP, heart rate, total cholesterol and NYHA class were significantly higher in the readmission group than in the non-readmission group ( p < 0.05). IL-1β, IL-6, IL-17, TNF-α, NT-proBNP, heart rate and NYHA class were identified as independent predictors of HF readmission. Conclusion: Inflammatory markers, including IL-1β, IL-6, IL-17 and TNF-α were related to the HF readmission in patients with HFpEF. Keywords: heart failure with preserved ejection fraction, inflammation, cytokine, readmission, risk assessment Heart failure (HF) is an advanced and terminal stage of various heart diseases. 1 It has a serious impact on patients' quality of life, increases hospitalization and mortality rates, and places a heavy economic burden on families and society. 2 The incidence of heart failure with preserved ejection fraction (HFpEF) has increased in recent year. 3 Management of HFpEF and prevention of heart failure progression is critical, as treatment options for HFpEF remain limited. 4 Previous studies showed that there was close relationship between repeated readmissions and the decline in physical status in patients with HF. 5 Also, it affected the patient's treatment compliance and lead to the decline of cardiac function. 6 Therefore, accurate assessment of patients' risk of readmission within 1 year is essential for early detection and intervention of disease and improve the prognosis of patients. Chronic Inflammation plays a vital role in the progression of HFpEF. 7 This chronic inflammatory state can lead to adverse cardiac remodeling and eventually heart failure. 8 It has been demonstrated that there was a strong association between various cytokines and HF. 9 However, only a few studies have investigated the association between cytokines and the risk of readmission in patients with heart failure with preserved ejection fraction within 1 year. The purpose of this study was to determine whether the expression of 12 cytokines [IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, interferon (IFN)-α, interferon (IFN)-γ, and tumor necrosis factor(TNF)-α] was differential in readmission group and non-readmission group in patients with HFpEF and whether they can be adopted to facilitate the early detection and intervention of disease in patients with HFpEF and improve the prognosis of patients. This retrospective study was based on the database of the Department of Cardiovascular Medicine, The Affiliated Municipal Hospital of Xuzhou Medical University from January 2020 to July 2022. The flow -Abstract Truncated-
immunology